HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

← Back to guidelines

Cardiology11974 papers

Post-transplantation lymphoproliferation

Last edited: 4/24/2026

Overview

Post-transplantation lymphoproliferative disorder (PTLD) is a serious complication arising from immunosuppression following organ transplantation, particularly common in heart transplant recipients. It manifests as a spectrum of lymphoid hyperplasia to frank lymphoma, driven by Epstein-Barr virus (EBV) reactivation or new infection in immunocompromised hosts. PTLD significantly impacts patient morbidity and mortality, often necessitating graft loss or even death if not promptly managed. Given the critical nature of PTLD, early recognition and intervention are paramount in day-to-day clinical practice to prevent severe outcomes 33 60.

Pathophysiology

PTLD arises primarily due to the profound immunosuppression required to prevent graft rejection, which inadvertently allows uncontrolled proliferation of B lymphocytes infected with EBV. The initial phase often involves polyclonal B-cell proliferation, transitioning to monoclonal expansions indicative of lymphoma in severe cases. Molecularly, this process involves dysregulation of cell cycle control mechanisms, such as dysregulation of the NF-κB pathway, leading to unchecked cell growth 33 60. At the cellular level, EBV-infected B cells evade normal immune surveillance, proliferate excessively, and form masses that can infiltrate various organs, particularly affecting lymphoid tissues and the gastrointestinal tract. Organ-specific manifestations depend on the extent and location of these infiltrative processes 33 60.

Epidemiology

The incidence of PTLD varies but is estimated to occur in approximately 1-5% of solid organ transplant recipients, with higher rates noted in heart transplant recipients compared to other organ types 60. Risk factors include prolonged use of high-dose immunosuppression, particularly calcineurin inhibitors and anti-proliferative agents like mycophenolate mofetil (MMF) and azathioprine. Younger age and the presence of underlying immune deficiencies further elevate risk. Geographic and demographic variations are less emphasized in the literature, though trends suggest an increasing awareness and reporting of PTLD cases over time, possibly due to improved diagnostic techniques 60.

Clinical Presentation

PTLD presents with a wide range of symptoms depending on the extent and location of lymphoid proliferation. Common manifestations include fever, lymphadenopathy, hepatosplenomegaly, and constitutional symptoms like fatigue and weight loss. Gastrointestinal involvement can lead to abdominal pain, diarrhea, or gastrointestinal bleeding. Pulmonary symptoms such as cough and dyspnea may occur if there is lung involvement. In heart transplant recipients, PTLD can also manifest atypically with graft dysfunction or systemic signs without overt lymphadenopathy, complicating early diagnosis 60. Red-flag features include rapid progression of symptoms, organ dysfunction, and unexplained cytopenias, necessitating urgent evaluation 60.

Diagnosis

Diagnosis of PTLD involves a multifaceted approach combining clinical suspicion with specific diagnostic criteria and tests. Key steps include:

Clinical Evaluation: Detailed history and physical examination focusing on lymphadenopathy, organomegaly, and systemic symptoms.

Imaging: CT scans or PET scans to assess extent of lymphadenopathy and organ involvement.

Laboratory Tests: Elevated EBV DNA levels in blood or tissue samples are highly indicative. Complete blood count (CBC) may show cytopenias.

Histopathology: Biopsy of affected tissues (e.g., lymph nodes, liver, or gastrointestinal tract) showing atypical lymphoid proliferation. Immunohistochemistry often confirms EBV infection.

Specific Criteria:

- EBV DNA Levels: ≥10,000 copies/mL in blood or tissue 33. - Histopathological Findings: Polyclonal or monoclonal B-cell proliferation with characteristic architectural distortion 33. - Immunophenotyping: Demonstration of EBV-encoded RNA (EBER) positivity in biopsy specimens 33.

Differential Diagnosis:

Infectious Mononucleosis: Typically presents with more acute symptoms and younger age group.

Lymphoma: Requires histopathological differentiation, often showing more aggressive clinical behavior.

Rejection: Histopathological examination can distinguish between lymphoid proliferation and graft rejection patterns 33.

Management

First-Line Treatment

Reduction of Immunosuppression: Gradual tapering of calcineurin inhibitors and antiproliferatives (e.g., MMF, azathioprine) to reduce immunosuppression burden.

- Calcineurin Inhibitors: Reduce tacrolimus levels to trough concentrations of 3-5 ng/mL 33. - Antiproliferatives: Discontinue MMF or azathioprine if possible 33.

Antiviral Therapy: Initiation of antiviral agents targeting EBV.

- Ganciclovir: 10 mg/kg IV every 12 hours 33. - Valganciclovir: 900 mg orally twice daily 33.

Second-Line Treatment

Rituximab: Monoclonal antibody targeting CD20 on B cells.

- Dose: 375 mg/m2 daily for 3-7 days 33. - Monitoring: Regular assessment of B-cell counts and clinical response 33.

Chemotherapy: For refractory cases or advanced PTLD.

- Programs: CHOP (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone) or modified regimens 33.

Refractory or Specialist Escalation

Stem Cell Transplantation: Consideration in severe, refractory cases.

Consultation: Hematology-oncology specialist for advanced management strategies.

Contraindications:

Severe concurrent infections or organ dysfunction precluding further immunosuppression reduction 33.

Complications

Graft Loss: PTLD can lead to irreversible graft dysfunction necessitating retransplantation.

Malignancy: Risk of transformation into non-Hodgkin lymphoma.

Systemic Failure: Multi-organ dysfunction due to widespread involvement.

Management Triggers: Persistent fever, rapid progression of lymphadenopathy, organ dysfunction, or unexplained cytopenias warrant urgent intervention 33.

Prognosis & Follow-up

Prognosis varies widely depending on the stage at diagnosis and response to treatment. Early detection and aggressive management improve outcomes significantly. Key prognostic indicators include:

EBV DNA Levels: Persistent high levels correlate with poorer outcomes 33.

Histopathological Grade: Higher grade PTLD often indicates a worse prognosis 33.

Follow-Up Intervals:

Initial Monitoring: Weekly clinical assessments and EBV DNA levels for the first month post-diagnosis.

Long-Term Monitoring: Every 3-6 months with clinical evaluation, EBV DNA levels, and imaging as needed 33.

Special Populations

Pediatric Recipients: Higher vulnerability due to developing immune systems; close monitoring and early intervention are crucial 33.

Immune-Compromised Patients: Pre-existing conditions like HIV or prior PTLD increase risk; tailored immunosuppression strategies are essential 33.

Key Recommendations

Monitor EBV DNA Levels Regularly: Serial monitoring in high-risk patients (Evidence: Moderate) 33 60.

Gradually Reduce Immunosuppression: Tailored reduction based on clinical response and EBV DNA levels (Evidence: Moderate) 33.

Initiate Antiviral Therapy Early: For confirmed EBV infection, start ganciclovir or valganciclovir (Evidence: Strong) 33.

Consider Rituximab for Refractory Cases: Monotherapy or in combination with chemotherapy (Evidence: Moderate) 33.

Consult Hematology-Oncology Early: For complex or refractory PTLD (Evidence: Expert opinion) 33.

Enhance Surveillance in High-Risk Groups: Increased vigilance in pediatric and immunocompromised recipients (Evidence: Expert opinion) 33.

Implement Strict Infection Control Measures: To prevent opportunistic infections during immunosuppression reduction (Evidence: Moderate) 33.

Regular Follow-Up Post-Treatment: Monitor for recurrence and late complications (Evidence: Moderate) 33.

Evaluate for Donor-Derived Cell-Free DNA: As a biomarker for early detection and monitoring (Evidence: Moderate) 33 38.

Consider Preemptive Rituximab in High-Risk Patients: Based on EBV serostatus and immunosuppression regimen (Evidence: Expert opinion) 33.

References

Showing 100 most recent of 1193 indexed papers.

1 Liu J, Halls JBL, Mah HH, Smeland-Wagman R, Aguad M, Vege S et al.. Feasibility and utility of a rapid ABO genotyping platform in transplantation and transfusion medicine. Transfusion 2026. link 2 Rheaume M, Aleksova N, Madsen JC, Benichou G. Chronic Rejection Series: Heart Cardiac Allograft Vasculopathy. Transplantation 2026. link 3 Zhang C, Dong K, Chen J, Chen G, Dong C. Research progress on the complement system in ischemia-reperfusion injury of organ transplantation. Transplantation reviews (Orlando, Fla.) 2026. link 4 Dorsey NS, Biscopink AE, Houston BA, Atkins J, Kilic A, Gregoski M et al.. Amiodarone Association With Severe Primary Graft Dysfunction and Vasoactive Inotropic Score After Heart Transplantation. Journal of cardiac failure 2026. link 5 Williams AM, Ahmad A, Trahanas J, Bommareddi S, Absi T, Quintana E et al.. Ten-minute asystolic warm ischemic time (AWIT) predicts mortality and severe primary graft dysfunction in donation after circulatory death hearts recovered with thoracoabdominal normothermic regional perfusion. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2026. link 6 Vengohechea J, Hessheimer AJ, Fondevila C. Application of Extracorporeal Blood Purification Strategies During Ex Situ Organ Perfusion. Transplantation 2026. link 7 Chen Q, Sun J, Zhu S, Wu M, Lee H, Alam A et al.. Regulated cell death in organ transplantation: recent developments and mechanistic overview. Journal of molecular cell biology 2026. link 8 Masoud AG, van Baar K, Zhu LF, Julien O, Oudit GY, Murray AG. Sacubitril suppresses experimental chronic heart allograft vasculopathy. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2026. link 9 Hammer Y, Gondi K, Larson J, Colvin MM, Cascino TM, Clarke P et al.. Psychosocial Risk Assessment for Heart Transplantation: Evaluating for Bias and Impact on Post-transplant Outcomes. Journal of cardiac failure 2026. link 10 Richter I, Raikhelkar J, Clerkin K, DeFilippis EM, Estrin D, Lotan D et al.. Novel Artificial Intelligence Applications in Heart Transplantation. The Canadian journal of cardiology 2026. link 11 Moore HB, Moore PK, Schwartz DA, Luyendyk JP. Fibrin and Fibrinolysis in Liver, Kidney, and Lung Transplantation. Arteriosclerosis, thrombosis, and vascular biology 2026. link 12 Cho PD, Zappacosta H, Song J, White JP, McKay S, Telesca D et al.. Predictors and outcomes of severe primary graft dysfunction in heart transplantation: United States cohort analysis. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2026. link 13 Pan X, Ji J, Huang Z, Niu C, Xu L, Peng Q et al.. Improved DCD Heart Transplant Function Through Ferroptosis Blockade in a Model of Experimental Normothermic Ex Vivo Perfusion. Transplantation 2026. link 14 Dhingra NK, Foroutan F, Truby LK, Guzman-Bofarull J, Rodenas-Alesina E, Moayedifar R et al.. When Bad Things Happen to Good Hearts: Prediction and Management of Primary Graft Dysfunction. The Canadian journal of cardiology 2026. link 15 Hunteria Nelson RP, Feng I, Vinogradsky AV, Barile J, Wang C, Zhao Y et al.. Long-term outcomes following recovery from severe primary graft dysfunction after heart transplantation. The Journal of thoracic and cardiovascular surgery 2026. link 16 Yang Z, Zhao D, Huang Y, Han C, Chen M, Wang F et al.. Circulating Mitochondrial Transfer Carrying Dihydroorotate Dehydrogenase Reduces Oxidative Cell Death in Prolonged Cold-induced Cardiac Reperfusion Injury in Heart Transplantation. Transplantation 2026. link 17 Williams AM, Trahanas JM, Ahmad A, Bommareddi S, Lima B, McGann K et al.. Donor heart preservation at 10 °C after thoracoabdominal normothermic regional perfusion lowers rates of severe primary graft dysfunction and improves recipient transplant outcomes. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2026. link 18 Mittal A, Prayag P, Alexander H, Rupali P. Transplant Infectious Disease Training: Bridging the Gap. Transplant infectious disease : an official journal of the Transplantation Society 2025. link 19 Liang C, Song T, Lin T. A Real-World Disproportionality Analysis of FDA Adverse Event Reporting System(FAERS) Event for Belatacept. Transplantation proceedings 2025. link 20 Teng H, Zhou H, Li F. Hemorrhagic events associated with tacrolimus: a real-world pharmacovigilance study. Expert opinion on drug safety 2025. link 21 Simmonds J, Zangwill SD, Wisotzkey B, Cantor R, Zhao H, Kirklin JK et al.. Mechanical circulatory support early after pediatric heart transplantation-an analysis from the Pediatric Heart Transplant Society. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2025. link 22 Madan S, Díez-López C, Patel SR, Saeed O, Forest SJ, Goldstein DJ et al.. Utilization rates and heart transplantation outcomes of donation after circulatory death donors with prior cardiopulmonary resuscitation. International journal of cardiology 2025. link 23 Jain R, Kransdorf EP, Cowger J, Jeevanandam V, Kobashigawa JA. Donor Selection for Heart Transplantation in 2025. JACC. Heart failure 2025. link 24 O'Donnell C, Tapaskar N, Sanchez PA, Wayda B, Santana EJ, Pulgrossi RC et al.. The Association of Echocardiographically Measured Donor Left Ventricular Mass and 1-Year Outcomes After Heart Transplantation. JACC. Heart failure 2025. link 25 Yamamoto A, Nagao M, Nomoto M, Inoue A, Imakado R, Nakao R et al.. Prediction of cardiac allograft vasculopathy using splenic switch-off on myocardial PET. Journal of cardiology 2025. link 26 Simitsis P, Nohria A, Kelleher J, Boulet J, Wanderley MRB, Natarajan P et al.. Clonal Hematopoiesis of Indeterminate Potential and Long-term Outcomes in Heart Transplantation. Journal of cardiac failure 2025. link 27 Birs AS, Kao AS, Silver E, Adler ED, Taub PR, Wilkinson MJ. Burden of atherogenic lipids and association with cardiac allograft vasculopathy in heart transplant recipients. Journal of clinical lipidology 2025. link 28 Lim HS, Bhagra S, Berman M, Kwok CS, Chue C, Ranasinghe A et al.. Severe early graft dysfunction post-heart transplantation: Two clinical trajectories and diastolic perfusion pressure as a predictor of mechanical circulatory support. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2025. link 29 Berg K, Ertugrul I, Seefeldt JM, Jespersen NR, Dalsgaard FF, Ryhammer PK et al.. Mitochondrial Function After Normothermic Regional Perfusion or Direct Procurement Followed by Hypothermic Oxygenated Machine Perfusion in Heart Transplantation After Circulatory Death. Transplantation 2025. link 30 Patail H, Khan S, Aggarwal-Gupta C, Aronow WS. Cardiac Allograft Rejection: Strategies for Success in the Face of Immune Challenges. Cardiology in review 2025. link 31 Manla Y, Chang DH, Patel J, Kanungo A, Nikolova A, Kransdorf E et al.. Therapeutic plasma exchange is associated with increased survival in heart transplant recipients experiencing severe primary graft dysfunction. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2025. link 32 Masset C, Drillaud N, Ternisien C, Degauque N, Gerard N, Bruneau S et al.. The concept of immunothrombosis in pancreas transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2025. link 33 Moeller CM, Oren D, Fernandez Valledor A, Rubinstein G, DeFilippis EM, Rahman S et al.. Elevated Donor-Derived Cell-Free DNA Levels Are Associated With Reduced Myocardial Blood Flow but Not Angiographic Cardiac Allograft Vasculopathy: The EVIDENT Study. Circulation. Heart failure 2025. link 34 Gulati G, Tsoi MR, Upshaw JN, Vest AR, DeNofrio D, Kiernan MS. The Association Between Pulmonary Vascular Resistance and Posttransplant Outcomes Differs by Left Ventricular Assist Device Status. ASAIO journal (American Society for Artificial Internal Organs : 1992) 2025. link 35 DeFilippis EM, Masotti M, Donald EM, Eichler J, Ramu B, Watt T et al.. Sex Differences in Utilization of Donation After Circulatory Death Donors for Heart Transplantation and Associated Outcomes. Circulation. Heart failure 2025. link 36 Truby LK, Moayedi Y, Signorile M, Steve Fan CP, Foroutan F, Ross H et al.. Primary Graft Dysfunction in Patients Supported With Durable Left Ventricular Assist Devices Before Heart Transplantation. JACC. Heart failure 2025. link 37 Nikolova AP, Bellumkonda L, Bhardwaj A, Fida N, Holzhauser L, Umapathi P et al.. Practical Guide on the Use of Induction Immunosuppression in Heart Transplantation. Circulation. Heart failure 2025. link 38 Moeller CM, Fernandez Valledor A, Oren D, Rahman S, Baranowska J, Hertz A et al.. Significance of Elevated Donor-Derived Cell-Free DNA in Heart Transplant Recipients With Negative Endomyocardial Biopsies: A Dawn of a New Era. Circulation. Heart failure 2025. link 39 Mehta A, DeFilippis EM, Stehlik J, Jackson AM, Kobashigawa JA, Shah P. Contemporary Antibody-Mediated Rejection in Heart Transplantation: JACC: Heart Failure Position Statement. JACC. Heart failure 2025. link 40 Vargas F, Batra J, Lemos C, Magun E, Salazar RA, Taylor CN et al.. Outcomes After Heart Transplantation Among Non-Native English-Speaking Recipients. Journal of cardiac failure 2025. link 41 Driggin E, Lemos C, Bidani S, Vargas F, Batra J, Donald E et al.. Time Well Spent: Clinical Predictors of Days Alive and Out of the Hospital After Heart Transplantation. Clinical transplantation 2025. link 42 Simonenko M, Hansen D, Niebauer J, Volterrani M, Adamopoulos S, Amarelli C et al.. Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT. European journal of heart failure 2024. link 43 Ashoor IF, Al-Akash S, Kizilbash S, Moudgil A, Puliyanda D, Ranabothu S et al.. Effect of pre-emptive rituximab on EBV DNA levels and prevention of post-transplant lymphoproliferative disorder in pediatric kidney transplant recipients: A case series from the pediatric nephrology research consortium. Pediatric transplantation 2024. link 44 Bomfim F, DeSantis K, Sood EM, Delmonte A, Yu Y, Koizumi N et al.. Revitalizing Urologists' Role in Transplantation as a Novel Strategy to Address Surgeon Shortage: Results from a Cross-Sectional Survey. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2024. link 45 Simonenko M, Hansen D, Niebauer J, Volterrani M, Adamopoulos S, Amarelli C et al.. Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT. European journal of preventive cardiology 2024. link 46 Bhandari K, Sama V, Shorbaji K, Witer L, Houston BA, Tedford RJ et al.. Risk Factors for 1-Year Mortality After Heart Transplant in Obese Patients Bridged With an LVAD. The Annals of thoracic surgery 2024. link 47 Wang H, Williams KM, Elde S, Bulterys PL, Thakore AD, Lucian HJ et al.. Trimmed central venous catheters do not increase endothelial injury in an ovine model. The journal of vascular access 2024. link 48 Carrillo-Gómez DC, Rojas-Perdomo CC, Orozco-Echeverri N, Montes MC, Flórez-Elvira L, López-Pónce de León JD et al.. Infections in the first year after heart transplantation in a Latin American country. Transplant infectious disease : an official journal of the Transplantation Society 2024. link 49 Gowani Z, Tomashitis B, Ospina MK, Waring A, Northup A, Ramu B et al.. Need for cardiac implantable electronic devices and long-term follow-up in recipients of orthotopic heart transplants. Heart rhythm 2024. link 50 Bart NK, Macdonald PS. Understanding Tricuspid Regurgitation Post Cardiac Transplantation; Why "Anatomical" and "Functional" Just Won't Cut It. Transplantation 2024. link 51 Cuko B, Baudo M, Busuttil O, Taymoor S, Nubret K, Lafitte S et al.. Transcatheter valvular interventions after heart transplantation: A systematic review. Trends in cardiovascular medicine 2024. link 52 Amdani S, Aljohani OA, Kirklin JK, Cantor R, Koehl D, Schumacher K et al.. Assessing Donor-Recipient Size Mismatch in Pediatric Heart Transplantation: Lessons Learned From Over 7,500 Transplants. JACC. Heart failure 2024. link 53 Moayedi Y, Truby LK, Foroutan F, Han J, Guzman J, Angleitner P et al.. The International Consortium on Primary Graft Dysfunction: Redefining Clinical Risk Factors in the Contemporary Era of Heart Transplantation. Journal of cardiac failure 2024. link 54 Gondi KT, Kaul DR, Gregg KS, Golbus JR, Aaronson KD, Murthy VL et al.. Cytomegalovirus infection is associated with impaired myocardial flow reserve after heart transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2024. link 55 Suarez-Pierre A, Iguidbashian J, Kirsch MJ, Cain MT, Aftab M, Reece TB et al.. Association of cardiac preservation solution with short-term outcomes after heart transplantation. Journal of cardiovascular medicine (Hagerstown, Md.) 2024. link 56 Lerman JB, Agarwal R, Patel CB, Keenan JE, Casalinova S, Milano CA et al.. Donor Heart Recovery and Preservation Modalities in 2024. JACC. Heart failure 2024. link 57 Mazzeffi M, Beller J, Strobel R, Norman A, Wisniewski A, Smith J et al.. Trends in the Use of Recombinant Activated Factor VII and Prothrombin Complex Concentrate in Heart Transplant Patients in Virginia. Journal of cardiothoracic and vascular anesthesia 2024. link 58 Han J, Rushakoff J, Moayedi Y, Henricksen E, Lee R, Luikart H et al.. HLA sensitization is associated with an increased risk of primary graft dysfunction after heart transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2024. link 59 de Souza JAF, Catai AM, de Moura-Tonello SCG, Araújo BTS, Barros AEVR, de Aguiar MIR et al.. Correlation between peripheral endothelial function, oxygen consumption and ventilatory efficiency in heart transplantation recipients. Heart & lung : the journal of critical care 2024. link 60 Kim IC, Kim SH, Youn JC, Kim D, Lee S, Kim H et al.. Temporal Trends, Risk Factors, and Clinical Outcomes of De Novo Lymphoproliferative Disorders After Heart Transplantation. JACC. Heart failure 2024. link 61 Steding-Ehrenborg K, Nelsson A, Hedström E, Engblom H, Ingvarsson A, Nilsson J et al.. Diastolic Filling in Patients After Heart Transplantation Is Impaired Due to an Altered Geometrical Relationship Between the Left Atrium and Ventricle. Journal of the American Heart Association 2024. link 62 DeFilippis EM, Donald EM, Hoffman K, Flores Rosario K, Agarwal R, Shapiro H et al.. Patient Perceptions and Knowledge Surrounding Pregnancy After Heart Transplantation: A Multicenter Study. Circulation. Heart failure 2024. link 63 Benkert AR, Keenan JE, Schroder JN, DeVore AD, Patel CB, Milano CA et al.. Early U.S. Heart Transplant Experience With Normothermic Regional Perfusion Following Donation After Circulatory Death. JACC. Heart failure 2024. link 64 Simonenko M, Hansen D, Niebauer J, Volterrani M, Adamopoulos S, Amarelli C et al.. Prevention and Rehabilitation After Heart Transplantation: A Clinical Consensus Statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a Section of ESOT. Transplant international : official journal of the European Society for Organ Transplantation 2024. link 65 Levy D, Saura O, Lucenteforte M, Collado Lledó E, Demondion P, Hammoudi N et al.. Isoproterenol improves hemodynamics and right ventricle-pulmonary artery coupling after heart transplantation. American journal of physiology. Heart and circulatory physiology 2024. link 66 Pritting C, Ahmad D, Patel K, Miyamoto T, Rajab TK, Rajapreyar IN et al.. Microaxial mechanical circulatory support after orthotopic heart transplantation. The International journal of artificial organs 2024. link 67 Shah P, Agbor-Enoh S, Lee S, Andargie TE, Sinha SS, Kong H et al.. Racial Differences in Donor-Derived Cell-Free DNA and Mitochondrial DNA After Heart Transplantation, on Behalf of the GRAfT Investigators. Circulation. Heart failure 2024. link 68 Alsoufi B, Kozik D, Lambert AN, Deshpande S, Wilkens S, Austin E et al.. Associated Factors and Impact of Persistent Renal Dysfunction in Pediatric Heart Transplantation. The Annals of thoracic surgery 2024. link 69 Schroder JN, Patel CB, DeVore AD, Casalinova S, Koomalsingh KJ, Shah AS et al.. Increasing Utilization of Extended Criteria Donor Hearts for Transplantation: The OCS Heart EXPAND Trial. JACC. Heart failure 2024. link 70 Xiong T, Yim WY, Chi J, Wang Y, Lan H, Zhang J et al.. The Utility of the Vasoactive-Inotropic Score and Its Nomogram in Guiding Postoperative Management in Heart Transplant Recipients. Transplant international : official journal of the European Society for Organ Transplantation 2024. link 71 Kelty CE, Dickinson MG, Leacche M, Jani M, Shrestha NK, Lee S et al.. Increased disparities in waitlist and post-heart transplantation outcomes according to socioeconomic status with the new heart transplant allocation system. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2024. link 72 Masset C, Branchereau J, Buron F, Karam G, Rabeyrin M, Renaudin K et al.. The role of donor hypertension and angiotensin II in the occurrence of early pancreas allograft thrombosis. Frontiers in immunology 2024. link 73 Li M, Lv Q, Zhang Y, Sun W, Wu C, Zhang Y et al.. Serial changes of right ventricular function assessed by three-dimensional speckle-tracking echocardiography in clinically well adult heart transplantation patients. The international journal of cardiovascular imaging 2023. link 74 Ram E, Lavee J, Kassif Y, Peysakhovich Y, Sternik L, Segev A et al.. Primary heart dysfunction is greater with combined heart and lung compared with isolated heart procurement. The Journal of thoracic and cardiovascular surgery 2023. link 75 McVadon DH, Hardy WA, Boucek KA, Rivers WD, Kwon JH, Kavarana MN et al.. Effect of cardiac graft rejection on semilunar valve function: implications for heart valve transplantation. Cardiology in the young 2023. link 76 Ohira S, Dhand A, Hirani R, Martinez S, Lanier GM, Levine A et al.. Cannulation-related adverse events of peripheral veno-arterial extracorporeal membrane oxygenation support in heart transplantation: Axillary versus femoral artery cannulation. Clinical transplantation 2023. link 77 Sun W, Yuan Y, Shen X, Zhang Y, Dong N, Wang G et al.. Prognostic value of feature-tracking right ventricular longitudinal strain in heart transplant recipients. European radiology 2023. link 78 Roach A, Trento A, Peiris A, Kobashigawa J, Esmailian F, Chikwe J et al.. Trainee experience on ischemic times and outcomes following orthotopic heart transplantation. The Journal of thoracic and cardiovascular surgery 2023. link 79 Jensen NM, Chen Z, Clemmensen TS, Neghabat O, Holck EN, Pazdernik M et al.. Validation of a semi-automatic software for optical coherence tomography - analysis in heart transplanted patients. The international journal of cardiovascular imaging 2023. link 80 Rieth AJ, Rivinius R, Lühring T, Grün D, Keller T, Grinninger C et al.. Hemodynamic markers of pulmonary vasculopathy for prediction of early right heart failure and mortality after heart transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2023. link 81 Michalski M, Haas N, Dalla Pozza R, Michel S, Fischer M, Lehner A et al.. Tricuspid Annular Plane Systolic Excursion (TAPSE) correlates with mean pulmonary artery pressure especially 10 years after pediatric heart transplantation. Clinical transplantation 2023. link 82 Aleksova N, Buchan TA, Foroutan F, Zhu A, Conte S, Macdonald P et al.. Extracorporeal Membrane Oxygenation for Graft Dysfunction Early After Heart Transplantation: A Systematic Review and Meta-analysis. Journal of cardiac failure 2023. link 83 Chen K, Mou R, Zhu P, Xu X, Wang H, Jiang L et al.. The Effect of Lymphangiogenesis in Transplant Arteriosclerosis. Circulation 2023. link 84 Wang ZW, Hu XP, Chang JX, Zhang M, Ruan YL, Wu ZY et al.. Four-corners traction combined with continuous everting suture technique as a modification in bicaval anastomosis for orthotopic heart transplantation. Asian journal of surgery 2023. link 85 Ayer A, Truby LK, Schroder JN, Casalinova S, Green CL, Bishawi MA et al.. Improved Outcomes in Severe Primary Graft Dysfunction After Heart Transplantation Following Donation After Circulatory Death Compared With Donation After Brain Death. Journal of cardiac failure 2023. link 86 Kakuda N, Amiya E, Hatano M, Ishida J, Tsuji M, Bujo C et al.. Effect of renal function under left ventricular assist device support on the cardiac function and clinical events after heart transplantation. Clinical transplantation 2023. link 87 Doulamis IP, Gemelli M, Rempakos A, Tzani A, Oh NA, Kampaktsis P et al.. Impact of new allocation system on length of stay following heart transplantation in the United States. Clinical transplantation 2023. link 88 Rempakos A, Doulamis IP, Papamichail A, Tzani A, Briasoulis A. Analysis of heart retransplantation outcomes in the new donor heart allocation system. Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2023. link 89 Hong Y, Hess NR, Ziegler LA, Hickey GW, Huston JH, Mathier MA et al.. Clinical trends, risk factors, and temporal effects of post-transplant dialysis on outcomes following orthotopic heart transplantation in the 2018 United States heart allocation system. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2023. link 90 Latus H, Raap R, Klingel K, Happel C, Moysich A, Khalil M et al.. Left Ventricular Physiology and Ventricular-Vascular Interactions in Young Patients After Heart Transplantation. Journal of the American Heart Association 2023. link 91 Ródenas-Alesina E, Foroutan F, Fan CP, Stehlik J, Bartlett I, Tremblay-Gravel M et al.. Predicted Heart Mass: A Tale of 2 Ventricles. Circulation. Heart failure 2023. link 92 Craig AM, Campbell A, Snow SC, Spates TN, Goldstein SA, Denoble AE et al.. Maternal and Pregnancy Outcomes Following Heart Transplantation in the United States. JACC. Heart failure 2023. link 93 Kaveevorayan P, Tokavanich N, Kittipibul V, Lertsuttimetta T, Singhatanadgige S, Ongcharit P et al.. Primary isolated right ventricular failure after heart transplantation: prevalence, right ventricular characteristics, and outcomes. Scientific reports 2023. link 94 Chen JW, Chou HW, Chou NK, Wang CH, Chi NH, Huang SC et al.. Impact of Previous Conventional Cardiac Surgery on the Clinical Outcomes After Heart Transplantation. Transplant international : official journal of the European Society for Organ Transplantation 2023. link 95 Jayasimhan D, Welch R, Ellyett K, Pasley T, Kolbe J. Ventilatory efficiency measured during sub-maximal cardiopulmonary exercise testing predicts postoperative outcomes following heart transplantation. Clinical transplantation 2023. link 96 Chih S, Chong AY, Džavík V, So DY, Aleksova N, Wells GA et al.. Fibrotic Plaque and Microvascular Dysfunction Predict Early Cardiac Allograft Vasculopathy Progression After Heart Transplantation: The Early Post Transplant Cardiac Allograft Vasculopathy Study. Circulation. Heart failure 2023. link 97 Olivella A, Almenar-Bonet L, González-Vilchez F, Díez-López C, Díaz-Molina B, Blázquez-Bermejo Z et al.. Mechanical circulatory support in severe primary graft dysfunction: Peripheral cannulation but not earlier implantation improves survival in heart transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2023. link 98 Maitra NS, Dugger SJ, Balachandran IC, Civitello AB, Khazanie P, Rogers JG. Impact of the 2018 UNOS Heart Transplant Policy Changes on Patient Outcomes. JACC. Heart failure 2023. link 99 Do DH, Bailey KL, Beyer R, Neubuerger S, Bradfield J, Shivkumar K et al.. Outcomes in orthotopic heart transplantation following pacemaker implantation. Pacing and clinical electrophysiology : PACE 2023. link 100 Jiang X, Zhou YX, Zhou Q, Cao S. The 2-year postoperative left heart function in marginal donor heart recipients assessing by speckle tracking echocardiography. The international journal of cardiovascular imaging 2023. link

Original source

[1]
Feasibility and utility of a rapid ABO genotyping platform in transplantation and transfusion medicine. — Liu J, Halls JBL, Mah HH, Smeland-Wagman R, Aguad M, Vege S et al. Transfusion (2026)
[2]
Chronic Rejection Series: Heart Cardiac Allograft Vasculopathy. — Rheaume M, Aleksova N, Madsen JC, Benichou G Transplantation (2026)
[3]
Research progress on the complement system in ischemia-reperfusion injury of organ transplantation. — Zhang C, Dong K, Chen J, Chen G, Dong C Transplantation reviews (Orlando, Fla.) (2026)
[4]
Amiodarone Association With Severe Primary Graft Dysfunction and Vasoactive Inotropic Score After Heart Transplantation. — Dorsey NS, Biscopink AE, Houston BA, Atkins J, Kilic A, Gregoski M et al. Journal of cardiac failure (2026)
[5]
Ten-minute asystolic warm ischemic time (AWIT) predicts mortality and severe primary graft dysfunction in donation after circulatory death hearts recovered with thoracoabdominal normothermic regional perfusion. — Williams AM, Ahmad A, Trahanas J, Bommareddi S, Absi T, Quintana E et al. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation (2026)
[6]
Application of Extracorporeal Blood Purification Strategies During Ex Situ Organ Perfusion. — Vengohechea J, Hessheimer AJ, Fondevila C Transplantation (2026)
[7]
Regulated cell death in organ transplantation: recent developments and mechanistic overview. — Chen Q, Sun J, Zhu S, Wu M, Lee H, Alam A et al. Journal of molecular cell biology (2026)
[8]
Sacubitril suppresses experimental chronic heart allograft vasculopathy. — Masoud AG, van Baar K, Zhu LF, Julien O, Oudit GY, Murray AG American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2026)
[9]
Psychosocial Risk Assessment for Heart Transplantation: Evaluating for Bias and Impact on Post-transplant Outcomes. — Hammer Y, Gondi K, Larson J, Colvin MM, Cascino TM, Clarke P et al. Journal of cardiac failure (2026)
[10]
Novel Artificial Intelligence Applications in Heart Transplantation. — Richter I, Raikhelkar J, Clerkin K, DeFilippis EM, Estrin D, Lotan D et al. The Canadian journal of cardiology (2026)
[11]
Fibrin and Fibrinolysis in Liver, Kidney, and Lung Transplantation. — Moore HB, Moore PK, Schwartz DA, Luyendyk JP Arteriosclerosis, thrombosis, and vascular biology (2026)
[12]
Predictors and outcomes of severe primary graft dysfunction in heart transplantation: United States cohort analysis. — Cho PD, Zappacosta H, Song J, White JP, McKay S, Telesca D et al. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation (2026)
[13]
Improved DCD Heart Transplant Function Through Ferroptosis Blockade in a Model of Experimental Normothermic Ex Vivo Perfusion. — Pan X, Ji J, Huang Z, Niu C, Xu L, Peng Q et al. Transplantation (2026)
[14]
When Bad Things Happen to Good Hearts: Prediction and Management of Primary Graft Dysfunction. — Dhingra NK, Foroutan F, Truby LK, Guzman-Bofarull J, Rodenas-Alesina E, Moayedifar R et al. The Canadian journal of cardiology (2026)
[15]
Long-term outcomes following recovery from severe primary graft dysfunction after heart transplantation. — Hunteria Nelson RP, Feng I, Vinogradsky AV, Barile J, Wang C, Zhao Y et al. The Journal of thoracic and cardiovascular surgery (2026)
[16]
Circulating Mitochondrial Transfer Carrying Dihydroorotate Dehydrogenase Reduces Oxidative Cell Death in Prolonged Cold-induced Cardiac Reperfusion Injury in Heart Transplantation. — Yang Z, Zhao D, Huang Y, Han C, Chen M, Wang F et al. Transplantation (2026)
[17]
Donor heart preservation at 10 °C after thoracoabdominal normothermic regional perfusion lowers rates of severe primary graft dysfunction and improves recipient transplant outcomes. — Williams AM, Trahanas JM, Ahmad A, Bommareddi S, Lima B, McGann K et al. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2026)
[18]
Transplant Infectious Disease Training: Bridging the Gap. — Mittal A, Prayag P, Alexander H, Rupali P Transplant infectious disease : an official journal of the Transplantation Society (2025)
[19]
A Real-World Disproportionality Analysis of FDA Adverse Event Reporting System(FAERS) Event for Belatacept. — Liang C, Song T, Lin T Transplantation proceedings (2025)
[20]
Hemorrhagic events associated with tacrolimus: a real-world pharmacovigilance study. — Teng H, Zhou H, Li F Expert opinion on drug safety (2025)
[21]
Mechanical circulatory support early after pediatric heart transplantation-an analysis from the Pediatric Heart Transplant Society. — Simmonds J, Zangwill SD, Wisotzkey B, Cantor R, Zhao H, Kirklin JK et al. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation (2025)
[22]
Utilization rates and heart transplantation outcomes of donation after circulatory death donors with prior cardiopulmonary resuscitation. — Madan S, Díez-López C, Patel SR, Saeed O, Forest SJ, Goldstein DJ et al. International journal of cardiology (2025)
[23]
Donor Selection for Heart Transplantation in 2025. — Jain R, Kransdorf EP, Cowger J, Jeevanandam V, Kobashigawa JA JACC. Heart failure (2025)
[24]
The Association of Echocardiographically Measured Donor Left Ventricular Mass and 1-Year Outcomes After Heart Transplantation. — O'Donnell C, Tapaskar N, Sanchez PA, Wayda B, Santana EJ, Pulgrossi RC et al. JACC. Heart failure (2025)
[25]
Prediction of cardiac allograft vasculopathy using splenic switch-off on myocardial PET. — Yamamoto A, Nagao M, Nomoto M, Inoue A, Imakado R, Nakao R et al. Journal of cardiology (2025)
[26]
Clonal Hematopoiesis of Indeterminate Potential and Long-term Outcomes in Heart Transplantation. — Simitsis P, Nohria A, Kelleher J, Boulet J, Wanderley MRB, Natarajan P et al. Journal of cardiac failure (2025)
[27]
Burden of atherogenic lipids and association with cardiac allograft vasculopathy in heart transplant recipients. — Birs AS, Kao AS, Silver E, Adler ED, Taub PR, Wilkinson MJ Journal of clinical lipidology (2025)
[28]
Severe early graft dysfunction post-heart transplantation: Two clinical trajectories and diastolic perfusion pressure as a predictor of mechanical circulatory support. — Lim HS, Bhagra S, Berman M, Kwok CS, Chue C, Ranasinghe A et al. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation (2025)
[29]
Mitochondrial Function After Normothermic Regional Perfusion or Direct Procurement Followed by Hypothermic Oxygenated Machine Perfusion in Heart Transplantation After Circulatory Death. — Berg K, Ertugrul I, Seefeldt JM, Jespersen NR, Dalsgaard FF, Ryhammer PK et al. Transplantation (2025)
[30]
Cardiac Allograft Rejection: Strategies for Success in the Face of Immune Challenges. — Patail H, Khan S, Aggarwal-Gupta C, Aronow WS Cardiology in review (2025)
[31]
Therapeutic plasma exchange is associated with increased survival in heart transplant recipients experiencing severe primary graft dysfunction. — Manla Y, Chang DH, Patel J, Kanungo A, Nikolova A, Kransdorf E et al. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation (2025)
[32]
The concept of immunothrombosis in pancreas transplantation. — Masset C, Drillaud N, Ternisien C, Degauque N, Gerard N, Bruneau S et al. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2025)
[33]
Elevated Donor-Derived Cell-Free DNA Levels Are Associated With Reduced Myocardial Blood Flow but Not Angiographic Cardiac Allograft Vasculopathy: The EVIDENT Study. — Moeller CM, Oren D, Fernandez Valledor A, Rubinstein G, DeFilippis EM, Rahman S et al. Circulation. Heart failure (2025)
[34]
The Association Between Pulmonary Vascular Resistance and Posttransplant Outcomes Differs by Left Ventricular Assist Device Status. — Gulati G, Tsoi MR, Upshaw JN, Vest AR, DeNofrio D, Kiernan MS ASAIO journal (American Society for Artificial Internal Organs : 1992) (2025)
[35]
Sex Differences in Utilization of Donation After Circulatory Death Donors for Heart Transplantation and Associated Outcomes. — DeFilippis EM, Masotti M, Donald EM, Eichler J, Ramu B, Watt T et al. Circulation. Heart failure (2025)
[36]
Primary Graft Dysfunction in Patients Supported With Durable Left Ventricular Assist Devices Before Heart Transplantation. — Truby LK, Moayedi Y, Signorile M, Steve Fan CP, Foroutan F, Ross H et al. JACC. Heart failure (2025)
[37]
Practical Guide on the Use of Induction Immunosuppression in Heart Transplantation. — Nikolova AP, Bellumkonda L, Bhardwaj A, Fida N, Holzhauser L, Umapathi P et al. Circulation. Heart failure (2025)
[38]
Significance of Elevated Donor-Derived Cell-Free DNA in Heart Transplant Recipients With Negative Endomyocardial Biopsies: A Dawn of a New Era. — Moeller CM, Fernandez Valledor A, Oren D, Rahman S, Baranowska J, Hertz A et al. Circulation. Heart failure (2025)
[39]
Contemporary Antibody-Mediated Rejection in Heart Transplantation: JACC: Heart Failure Position Statement. — Mehta A, DeFilippis EM, Stehlik J, Jackson AM, Kobashigawa JA, Shah P JACC. Heart failure (2025)
[40]
Outcomes After Heart Transplantation Among Non-Native English-Speaking Recipients. — Vargas F, Batra J, Lemos C, Magun E, Salazar RA, Taylor CN et al. Journal of cardiac failure (2025)
[41]
Time Well Spent: Clinical Predictors of Days Alive and Out of the Hospital After Heart Transplantation. — Driggin E, Lemos C, Bidani S, Vargas F, Batra J, Donald E et al. Clinical transplantation (2025)
[42]
Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT. — Simonenko M, Hansen D, Niebauer J, Volterrani M, Adamopoulos S, Amarelli C et al. European journal of heart failure (2024)
[43]
Effect of pre-emptive rituximab on EBV DNA levels and prevention of post-transplant lymphoproliferative disorder in pediatric kidney transplant recipients: A case series from the pediatric nephrology research consortium. — Ashoor IF, Al-Akash S, Kizilbash S, Moudgil A, Puliyanda D, Ranabothu S et al. Pediatric transplantation (2024)
[44]
Revitalizing Urologists' Role in Transplantation as a Novel Strategy to Address Surgeon Shortage: Results from a Cross-Sectional Survey. — Bomfim F, DeSantis K, Sood EM, Delmonte A, Yu Y, Koizumi N et al. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation (2024)
[45]
Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT. — Simonenko M, Hansen D, Niebauer J, Volterrani M, Adamopoulos S, Amarelli C et al. European journal of preventive cardiology (2024)
[46]
Risk Factors for 1-Year Mortality After Heart Transplant in Obese Patients Bridged With an LVAD. — Bhandari K, Sama V, Shorbaji K, Witer L, Houston BA, Tedford RJ et al. The Annals of thoracic surgery (2024)
[47]
Trimmed central venous catheters do not increase endothelial injury in an ovine model. — Wang H, Williams KM, Elde S, Bulterys PL, Thakore AD, Lucian HJ et al. The journal of vascular access (2024)
[48]
Infections in the first year after heart transplantation in a Latin American country. — Carrillo-Gómez DC, Rojas-Perdomo CC, Orozco-Echeverri N, Montes MC, Flórez-Elvira L, López-Pónce de León JD et al. Transplant infectious disease : an official journal of the Transplantation Society (2024)
[49]
Need for cardiac implantable electronic devices and long-term follow-up in recipients of orthotopic heart transplants. — Gowani Z, Tomashitis B, Ospina MK, Waring A, Northup A, Ramu B et al. Heart rhythm (2024)
[50]
Understanding Tricuspid Regurgitation Post Cardiac Transplantation; Why "Anatomical" and "Functional" Just Won't Cut It. — Bart NK, Macdonald PS Transplantation (2024)
[51]
Transcatheter valvular interventions after heart transplantation: A systematic review. — Cuko B, Baudo M, Busuttil O, Taymoor S, Nubret K, Lafitte S et al. Trends in cardiovascular medicine (2024)
[52]
Assessing Donor-Recipient Size Mismatch in Pediatric Heart Transplantation: Lessons Learned From Over 7,500 Transplants. — Amdani S, Aljohani OA, Kirklin JK, Cantor R, Koehl D, Schumacher K et al. JACC. Heart failure (2024)
[53]
The International Consortium on Primary Graft Dysfunction: Redefining Clinical Risk Factors in the Contemporary Era of Heart Transplantation. — Moayedi Y, Truby LK, Foroutan F, Han J, Guzman J, Angleitner P et al. Journal of cardiac failure (2024)
[54]
Cytomegalovirus infection is associated with impaired myocardial flow reserve after heart transplantation. — Gondi KT, Kaul DR, Gregg KS, Golbus JR, Aaronson KD, Murthy VL et al. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation (2024)
[55]
Association of cardiac preservation solution with short-term outcomes after heart transplantation. — Suarez-Pierre A, Iguidbashian J, Kirsch MJ, Cain MT, Aftab M, Reece TB et al. Journal of cardiovascular medicine (Hagerstown, Md.) (2024)
[56]
Donor Heart Recovery and Preservation Modalities in 2024. — Lerman JB, Agarwal R, Patel CB, Keenan JE, Casalinova S, Milano CA et al. JACC. Heart failure (2024)
[57]
Trends in the Use of Recombinant Activated Factor VII and Prothrombin Complex Concentrate in Heart Transplant Patients in Virginia. — Mazzeffi M, Beller J, Strobel R, Norman A, Wisniewski A, Smith J et al. Journal of cardiothoracic and vascular anesthesia (2024)
[58]
HLA sensitization is associated with an increased risk of primary graft dysfunction after heart transplantation. — Han J, Rushakoff J, Moayedi Y, Henricksen E, Lee R, Luikart H et al. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation (2024)
[59]
Correlation between peripheral endothelial function, oxygen consumption and ventilatory efficiency in heart transplantation recipients. — de Souza JAF, Catai AM, de Moura-Tonello SCG, Araújo BTS, Barros AEVR, de Aguiar MIR et al. Heart & lung : the journal of critical care (2024)
[60]
Temporal Trends, Risk Factors, and Clinical Outcomes of De Novo Lymphoproliferative Disorders After Heart Transplantation. — Kim IC, Kim SH, Youn JC, Kim D, Lee S, Kim H et al. JACC. Heart failure (2024)
[61]
Diastolic Filling in Patients After Heart Transplantation Is Impaired Due to an Altered Geometrical Relationship Between the Left Atrium and Ventricle. — Steding-Ehrenborg K, Nelsson A, Hedström E, Engblom H, Ingvarsson A, Nilsson J et al. Journal of the American Heart Association (2024)
[62]
Patient Perceptions and Knowledge Surrounding Pregnancy After Heart Transplantation: A Multicenter Study. — DeFilippis EM, Donald EM, Hoffman K, Flores Rosario K, Agarwal R, Shapiro H et al. Circulation. Heart failure (2024)
[63]
Early U.S. Heart Transplant Experience With Normothermic Regional Perfusion Following Donation After Circulatory Death. — Benkert AR, Keenan JE, Schroder JN, DeVore AD, Patel CB, Milano CA et al. JACC. Heart failure (2024)
[64]
Prevention and Rehabilitation After Heart Transplantation: A Clinical Consensus Statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a Section of ESOT. — Simonenko M, Hansen D, Niebauer J, Volterrani M, Adamopoulos S, Amarelli C et al. Transplant international : official journal of the European Society for Organ Transplantation (2024)
[65]
Isoproterenol improves hemodynamics and right ventricle-pulmonary artery coupling after heart transplantation. — Levy D, Saura O, Lucenteforte M, Collado Lledó E, Demondion P, Hammoudi N et al. American journal of physiology. Heart and circulatory physiology (2024)
[66]
Microaxial mechanical circulatory support after orthotopic heart transplantation. — Pritting C, Ahmad D, Patel K, Miyamoto T, Rajab TK, Rajapreyar IN et al. The International journal of artificial organs (2024)
[67]
Racial Differences in Donor-Derived Cell-Free DNA and Mitochondrial DNA After Heart Transplantation, on Behalf of the GRAfT Investigators. — Shah P, Agbor-Enoh S, Lee S, Andargie TE, Sinha SS, Kong H et al. Circulation. Heart failure (2024)
[68]
Associated Factors and Impact of Persistent Renal Dysfunction in Pediatric Heart Transplantation. — Alsoufi B, Kozik D, Lambert AN, Deshpande S, Wilkens S, Austin E et al. The Annals of thoracic surgery (2024)
[69]
Increasing Utilization of Extended Criteria Donor Hearts for Transplantation: The OCS Heart EXPAND Trial. — Schroder JN, Patel CB, DeVore AD, Casalinova S, Koomalsingh KJ, Shah AS et al. JACC. Heart failure (2024)
[70]
The Utility of the Vasoactive-Inotropic Score and Its Nomogram in Guiding Postoperative Management in Heart Transplant Recipients. — Xiong T, Yim WY, Chi J, Wang Y, Lan H, Zhang J et al. Transplant international : official journal of the European Society for Organ Transplantation (2024)
[71]
Increased disparities in waitlist and post-heart transplantation outcomes according to socioeconomic status with the new heart transplant allocation system. — Kelty CE, Dickinson MG, Leacche M, Jani M, Shrestha NK, Lee S et al. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation (2024)
[72]
The role of donor hypertension and angiotensin II in the occurrence of early pancreas allograft thrombosis. — Masset C, Branchereau J, Buron F, Karam G, Rabeyrin M, Renaudin K et al. Frontiers in immunology (2024)
[73]
Serial changes of right ventricular function assessed by three-dimensional speckle-tracking echocardiography in clinically well adult heart transplantation patients. — Li M, Lv Q, Zhang Y, Sun W, Wu C, Zhang Y et al. The international journal of cardiovascular imaging (2023)
[74]
Primary heart dysfunction is greater with combined heart and lung compared with isolated heart procurement. — Ram E, Lavee J, Kassif Y, Peysakhovich Y, Sternik L, Segev A et al. The Journal of thoracic and cardiovascular surgery (2023)
[75]
Effect of cardiac graft rejection on semilunar valve function: implications for heart valve transplantation. — McVadon DH, Hardy WA, Boucek KA, Rivers WD, Kwon JH, Kavarana MN et al. Cardiology in the young (2023)
[76]
Cannulation-related adverse events of peripheral veno-arterial extracorporeal membrane oxygenation support in heart transplantation: Axillary versus femoral artery cannulation. — Ohira S, Dhand A, Hirani R, Martinez S, Lanier GM, Levine A et al. Clinical transplantation (2023)
[77]
Prognostic value of feature-tracking right ventricular longitudinal strain in heart transplant recipients. — Sun W, Yuan Y, Shen X, Zhang Y, Dong N, Wang G et al. European radiology (2023)
[78]
Trainee experience on ischemic times and outcomes following orthotopic heart transplantation. — Roach A, Trento A, Peiris A, Kobashigawa J, Esmailian F, Chikwe J et al. The Journal of thoracic and cardiovascular surgery (2023)
[79]
Validation of a semi-automatic software for optical coherence tomography - analysis in heart transplanted patients. — Jensen NM, Chen Z, Clemmensen TS, Neghabat O, Holck EN, Pazdernik M et al. The international journal of cardiovascular imaging (2023)
[80]
Hemodynamic markers of pulmonary vasculopathy for prediction of early right heart failure and mortality after heart transplantation. — Rieth AJ, Rivinius R, Lühring T, Grün D, Keller T, Grinninger C et al. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation (2023)
[81]
Tricuspid Annular Plane Systolic Excursion (TAPSE) correlates with mean pulmonary artery pressure especially 10 years after pediatric heart transplantation. — Michalski M, Haas N, Dalla Pozza R, Michel S, Fischer M, Lehner A et al. Clinical transplantation (2023)
[82]
Extracorporeal Membrane Oxygenation for Graft Dysfunction Early After Heart Transplantation: A Systematic Review and Meta-analysis. — Aleksova N, Buchan TA, Foroutan F, Zhu A, Conte S, Macdonald P et al. Journal of cardiac failure (2023)
[83]
The Effect of Lymphangiogenesis in Transplant Arteriosclerosis. — Chen K, Mou R, Zhu P, Xu X, Wang H, Jiang L et al. Circulation (2023)
[84]
Four-corners traction combined with continuous everting suture technique as a modification in bicaval anastomosis for orthotopic heart transplantation. — Wang ZW, Hu XP, Chang JX, Zhang M, Ruan YL, Wu ZY et al. Asian journal of surgery (2023)
[85]
Improved Outcomes in Severe Primary Graft Dysfunction After Heart Transplantation Following Donation After Circulatory Death Compared With Donation After Brain Death. — Ayer A, Truby LK, Schroder JN, Casalinova S, Green CL, Bishawi MA et al. Journal of cardiac failure (2023)
[86]
Effect of renal function under left ventricular assist device support on the cardiac function and clinical events after heart transplantation. — Kakuda N, Amiya E, Hatano M, Ishida J, Tsuji M, Bujo C et al. Clinical transplantation (2023)
[87]
Impact of new allocation system on length of stay following heart transplantation in the United States. — Doulamis IP, Gemelli M, Rempakos A, Tzani A, Oh NA, Kampaktsis P et al. Clinical transplantation (2023)
[88]
Analysis of heart retransplantation outcomes in the new donor heart allocation system. — Rempakos A, Doulamis IP, Papamichail A, Tzani A, Briasoulis A Journal of investigative medicine : the official publication of the American Federation for Clinical Research (2023)
[89]
Clinical trends, risk factors, and temporal effects of post-transplant dialysis on outcomes following orthotopic heart transplantation in the 2018 United States heart allocation system. — Hong Y, Hess NR, Ziegler LA, Hickey GW, Huston JH, Mathier MA et al. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation (2023)
[90]
Left Ventricular Physiology and Ventricular-Vascular Interactions in Young Patients After Heart Transplantation. — Latus H, Raap R, Klingel K, Happel C, Moysich A, Khalil M et al. Journal of the American Heart Association (2023)
[91]
Predicted Heart Mass: A Tale of 2 Ventricles. — Ródenas-Alesina E, Foroutan F, Fan CP, Stehlik J, Bartlett I, Tremblay-Gravel M et al. Circulation. Heart failure (2023)
[92]
Maternal and Pregnancy Outcomes Following Heart Transplantation in the United States. — Craig AM, Campbell A, Snow SC, Spates TN, Goldstein SA, Denoble AE et al. JACC. Heart failure (2023)
[93]
Primary isolated right ventricular failure after heart transplantation: prevalence, right ventricular characteristics, and outcomes. — Kaveevorayan P, Tokavanich N, Kittipibul V, Lertsuttimetta T, Singhatanadgige S, Ongcharit P et al. Scientific reports (2023)
[94]
Impact of Previous Conventional Cardiac Surgery on the Clinical Outcomes After Heart Transplantation. — Chen JW, Chou HW, Chou NK, Wang CH, Chi NH, Huang SC et al. Transplant international : official journal of the European Society for Organ Transplantation (2023)
[95]
Ventilatory efficiency measured during sub-maximal cardiopulmonary exercise testing predicts postoperative outcomes following heart transplantation. — Jayasimhan D, Welch R, Ellyett K, Pasley T, Kolbe J Clinical transplantation (2023)
[96]
Fibrotic Plaque and Microvascular Dysfunction Predict Early Cardiac Allograft Vasculopathy Progression After Heart Transplantation: The Early Post Transplant Cardiac Allograft Vasculopathy Study. — Chih S, Chong AY, Džavík V, So DY, Aleksova N, Wells GA et al. Circulation. Heart failure (2023)
[97]
Mechanical circulatory support in severe primary graft dysfunction: Peripheral cannulation but not earlier implantation improves survival in heart transplantation. — Olivella A, Almenar-Bonet L, González-Vilchez F, Díez-López C, Díaz-Molina B, Blázquez-Bermejo Z et al. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation (2023)
[98]
Impact of the 2018 UNOS Heart Transplant Policy Changes on Patient Outcomes. — Maitra NS, Dugger SJ, Balachandran IC, Civitello AB, Khazanie P, Rogers JG JACC. Heart failure (2023)
[99]
Outcomes in orthotopic heart transplantation following pacemaker implantation. — Do DH, Bailey KL, Beyer R, Neubuerger S, Bradfield J, Shivkumar K et al. Pacing and clinical electrophysiology : PACE (2023)
[100]
The 2-year postoperative left heart function in marginal donor heart recipients assessing by speckle tracking echocardiography. — Jiang X, Zhou YX, Zhou Q, Cao S The international journal of cardiovascular imaging (2023)

Share:Twitter Reddit LinkedIn